Meda to buy OTC product for dental erosion

19 December 2013 - Deborah Wilkes

Archived

Meda is set to acquire ZpearPoint – including global rights to its EB24 OTC product for treating dental erosion – in a deal worth up to SEK77.0 million (US$11.8 million).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: